Profound Medical (Canada)
The TULSA Procedure offers customizable treatment planning and 360-degree targeting capability, providing physicians with the flexibility to ablate prescribed tissue volumes in men with localized prostate cancer, prostate cancer combined with obstructive BPH, localized radiorecurrent prostate cancer, or large volume BPH. The CAPTAIN trial marks an important milestone in prostate cancer treatment. As the first multi-center randomized controlled trial to successfully enroll to target while directl
Basic Information
- Category: business
- Website: http://www.profoundmedical.com/
Documented Facts
- Inception (Wikidata): 2008 (Source 2: Wikidata Q50038895, revision 2474195034)
- Country (Wikidata; date unspecified): Canada (Source 2: Wikidata Q50038895, revision 2474195034; Source 3: Wikidata label: Q16, revision 2555105353)
- Official website (Wikidata; date unspecified): http://www.profoundmedical.com/ (Source 2: Wikidata Q50038895, revision 2474195034)
Evidence and Sources
- Profound Medical (Canada) — Official Website (official)
- Wikidata Q50038895, revision 2474195034 (knowledge-base)
- Wikidata label: Q16, revision 2555105353 (knowledge-base)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Profound Medical (Canada).
- Canonical profile: https://brandsource.ai/brands/profound-medical-canada
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/profound-medical-canada/json-ld
- Citation profile API: https://brandsource.ai/api/brands/profound-medical-canada/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (91/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
The TULSA Procedure offers customizable treatment planning and 360-degree targeting capability, providing physicians with the flexibility to ablate prescribed tissue volumes in men with localized prostate cancer, prostate cancer combined with obstructive BPH, localized radiorecurrent prostate cancer, or large volume BPH. The CAPTAIN trial marks an important milestone in prostate cancer treatment. As the first multi-center randomized controlled trial to successfully enroll to target while directl
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 3 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.